Published by
@ShahidNShah
@ShahidNShah
Healthcare Data Protection in a Post-Brexit World
After three-and-a-half years of deliberations, the UK officially left the European on January 31st. A transition period until the end of this year will see both stakeholders drawing up a number of agreements, with trade being at the forefront.
Continue reading at healthmanagement.org
Make faster decisions with community advice
- Most Innovative Cancer Drugs Are Not Prioritised
- How Robotic Process Automation (RPA) Can Improve Clinical Outcomes
- Long-Awaited HHS Data Sharing Rules Raise Privacy Worries
- National language processing: The key that unlocks improvements to patient safety and quality
- Hospitals at risk from new Microsoft software vulnerabilities: How to respond
Next Article
-
Most Innovative Cancer Drugs Are Not Prioritised
In an overview of all drugs licenced through the European Medicines Agency (EMA) from 2000 to the end of 2016, the research team from The Institute of Cancer Research (London) found that increasing …
Posted Feb 3, 2020cancerdrugs
